Akers Bio logo
Akers Biosciences Announces Its Financial Results for Third Quarter 2014
13 nov. 2014 07h00 HE | Akers Biosciences Inc.
THOROFARE, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and testing...
Akers Bio logo
Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results
10 nov. 2014 07h00 HE | Akers Biosciences Inc.
THOROFARE, N.J., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Bio logo
Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
23 oct. 2014 08h17 HE | Akers Biosciences Inc.
THOROFARE, N.J., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Bio logo
Akers Biosciences Features on Global Broadcast & Online Media
16 sept. 2014 12h45 HE | Akers Biosciences Inc.
THOROFARE, N.J., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces...
Akers Bio logo
Akers Biosciences Presenting at US Investor Conferences
09 sept. 2014 13h42 HE | Akers Biosciences Inc.
Executive Chairman Raymond F. Akers Jr., Ph.D, to present at: Rodman & Renshaw 16th Annual Global Investment Conference; and Aegis Capital Corporation 2014 Healthcare & Technology...
Akers Bio logo
Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
09 sept. 2014 07h30 HE | Akers Biosciences Inc.
THOROFARE, N.J., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Bio logo
Akers Biosciences Reports Its Second Quarter Financial Results
12 août 2014 07h00 HE | Akers Biosciences Inc.
Sales of flagship PIFA Heparin/PF4 products increasing Conference call scheduled for 10:15 a.m. ET today THOROFARE, N.J., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER)...
Akers Bio logo
Akers Biosciences Announces Conference Call to Discuss Its Second Quarter and Six Months Financial Results
11 août 2014 12h17 HE | Akers Biosciences Inc.
THOROFARE, N.J., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Bio logo
Akers Appoints New Vice President of International Sales and Marketing to Build International Business
05 août 2014 02h00 HE | Akers Biosciences Inc.
THOROFARE, N.J., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...
Akers Bio logo
Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
28 juil. 2014 02h00 HE | Akers Biosciences Inc.
THOROFARE, N.J., July 28, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and...